Immune markers in ICU patients with pneumonia
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This study looks at how the immune system reacts in ICU patients on a ventilator who have pneumonia. By measuring immune markers, the researchers hope to better understand and predict complications like ventilator-associated pneumonia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You are in the ICU and on a breathing machine (ventilator)
- You have pneumonia caused by an infection
- Your immune system is not severely weakened (e.g., from HIV, certain cancers, or a low white blood cell count)
- You have not been on steroids or certain immune-suppressing drugs before coming to the ICU
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at changes (biomarkers) in the blood or other samples from people on a breathing machine. It may help doctors detect ventilator-associated pneumonia earlier and tailor treatment sooner.
This trial looks at how well doctors followed current guidelines to diagnose ventilator-associated pneumonia (a lung infection from a breathing tube) in ICU patients between 2022 and 2024. It aims to improve future care.
This study tests whether using a DNA test on lung fluid can help doctors choose better antibiotics for pneumonia in ICU patients with weakened immune systems. It may lead to more effective treatment and fewer side effects.
This study looks at different types of lung infections in ICU patients on breathing machines. By analyzing fluid from your lungs, researchers hope to better understand pneumonia and improve treatment.
This study looks at immune cells in the lungs of people on breathing machines. It aims to understand how these cells change in patients who develop pneumonia while on the ventilator.
This study follows people who are admitted to a respiratory intensive care unit (a special ICU for breathing problems) because they have pneumonia. It may help doctors better understand pneumonia in ICU patients and improve care in the future.
Hear when a new Pneumonia, Ventilator-Associated trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.